These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma. Ververeli K; Chipps B Ann Allergy Asthma Immunol; 2004 May; 92(5):512-22. PubMed ID: 15191019 [TBL] [Abstract][Full Text] [Related]
3. Methotrexate for the treatment of chronic corticosteroid-dependent asthma. Reid DJ; Segars LW Clin Pharm; 1993 Oct; 12(10):762-7. PubMed ID: 8258256 [TBL] [Abstract][Full Text] [Related]
4. Anti-immunoglobulin E therapy with omalizumab for asthma. Hendeles L; Sorkness CA Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897 [TBL] [Abstract][Full Text] [Related]
5. Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids. Domingo C; Moreno A; Mirapeix R Intern Med J; 2011 Jul; 41(7):525-36. PubMed ID: 21762333 [TBL] [Abstract][Full Text] [Related]
6. Omalizumab: a novel therapy for allergic asthma. Davis LA Ann Pharmacother; 2004; 38(7-8):1236-42. PubMed ID: 15187202 [TBL] [Abstract][Full Text] [Related]
7. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. Halpern MT; Schmier JK; Van Kerkhove MD; Watkins M; Kalberg CJ Ann Allergy Asthma Immunol; 2004 Feb; 92(2):201-7; quiz 207-8, 267. PubMed ID: 14989387 [TBL] [Abstract][Full Text] [Related]
8. Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients. Domingo C; Moreno A; José Amengual M; Montón C; Suárez D; Pomares X Curr Med Res Opin; 2011 Jan; 27(1):45-53. PubMed ID: 21083517 [TBL] [Abstract][Full Text] [Related]
9. Nebulized lidocaine in the treatment of severe asthma in children: a pilot study. Decco ML; Neeno TA; Hunt LW; O'Connell EJ; Yunginger JW; Sachs MI Ann Allergy Asthma Immunol; 1999 Jan; 82(1):29-32. PubMed ID: 9988203 [TBL] [Abstract][Full Text] [Related]
10. Is there a best outcome measurement for patients with asthma? Kemp J Ann Allergy Asthma Immunol; 2006 Oct; 97(4):432-9. PubMed ID: 17069093 [TBL] [Abstract][Full Text] [Related]
12. Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: real-life data. Molimard M; Buhl R; Niven R; Le Gros V; Thielen A; Thirlwell J; Maykut R; Peachey G Respir Med; 2010 Sep; 104(9):1381-5. PubMed ID: 20599369 [TBL] [Abstract][Full Text] [Related]
13. Measures to reduce maintenance therapy with oral corticosteroid in adults with severe asthma. Nguyen VQ; Ulrik CS Allergy Asthma Proc; 2016 Nov; 37(6):125-139. PubMed ID: 27931289 [TBL] [Abstract][Full Text] [Related]
14. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Leone FT; Fish JE; Szefler SJ; West SL Chest; 2003 Dec; 124(6):2329-40. PubMed ID: 14665517 [TBL] [Abstract][Full Text] [Related]
15. Evidence for therapeutic uses of nebulized lidocaine in the treatment of intractable cough and asthma. Slaton RM; Thomas RH; Mbathi JW Ann Pharmacother; 2013 Apr; 47(4):578-85. PubMed ID: 23548650 [TBL] [Abstract][Full Text] [Related]